Nephrocare Health Services Ltd Share Price

Hospitals / Medical ServicesNSE
₹637.65
-11.30-1.74% (1D)
As on 5 Oct 2026 at 15:52
As of 5 Oct 2026 at 15:52, Nephrocare Health Services Ltd is trading at ₹637.65. The 52-week range stands at ₹446.00–₹781.50, with a market cap of ₹6.41 thousand crore. At a P/E of 0.00 and a dividend yield of 0.00%, it is a mid-cap stock in the Healthcare sector.

NEPHROPLUS Price Chart

Market Cap
₹6.41K Cr
PE Ratio
0.00
ROCE
4.68%

Nephrocare Health Services Ltd Performance

Nephrocare Health Services Ltd Fundamentals

Market Cap₹6.41K Cr
ROE-0.83%
P/E Ratio (TTM)0.00
EPS (TTM)₹0.00
P/B Ratio6.60
Dividend Yield0.00%
Industry P/E194.65
Book Value₹96.56
Debt to Equity0.01
Face Value₹2

Nephrocare Health Services Ltd Shareholding Pattern

Promoter63.9%
Foreign Institutions8.8%
Mutual Funds3.2%
Domestic Institutions5.8%
Public18.3%

Nephrocare Health Services Ltd Financial Statements

0200400600800₹544FY25+15.85%₹630FY26

*All values are in INR Crore

Nephrocare Health Services Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹8,010.00
-123.50(-1.52%)
1,15,171.56,696.5 - 9,070.5
Max Healthcare Institute Ltd
₹916.60
-24.35(-2.59%)
89,213.6902.1 - 1,221.9
Manipal Health Enterprises Ltd
₹667.30
-28.70(-4.12%)
87,775.1625.5 - 815.0
Aster DM Quality Care Ltd
₹691.00
-17.90(-2.53%)
60,232.6519.1 - 891.3
Fortis Healthcare Ltd
₹765.00
-20.00(-2.55%)
57,754.3745.4 - 1,104.3

About Nephrocare Health Services

Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009. Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre. The Company set out to address critical gaps in dialysis care through better access, higher clinical standards and a patient-first approach. It provides comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The Company the business in 2010 with the launch of its first dialysis clinic in Hyderabad. It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd. in 2018; launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc in 2020. The Company acquired 6 clinics dialysis network with 35000 annual tretaments in 2023 . Further, it has acquired a chain of 7 clinics dialysis network such as AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc. in FY25. Company came up with the IPO by issuing 18,943,264 Equity Shares having the face value of Rs 2 each and raised funds aggregating to Rs 871.04 crore, comprising a fresh issue of 7,690,162 Equity Shares amounting to Rs 353.4 crore and the offer for sale of 11,253,102 Equity shares amounting to Rs 517.64 crore on December 12, 2025. During FY 2026, Company built an integrated technology ecosystem that connects patients, clinicians, operations, and enterprise functions through cloud computing, artificial intelligence, automation, and data-driven insights. It further expanded the AI platform patient engagement, clinical workflows, operations, and business functions to scale the operations. The Company served 1400+ guests across 6 clinics in 2026. .

Parent Organisation—
Founded2009
Managing Director—
NSE SymbolNEPHROPLUS

Nephrocare Health Services Ltd Resistance and Support levels

R3674.42R2664.81R1658.87S1639.66S2633.72S3624.12637.65

Nephrocare Health Services Ltd Technicals

Current Price
₹637.65 ₹11.30 (-1.74%)
Bearish
10
Bullish
2
  • 20 Day9.2%
  • 50 Day8.5%
  • 100 Day4.8%
  • 200 Day5.1%

Nephrocare Health Services Ltd Latest News

View More
25 SEPT 2026 | Friday
Nephrocare Health Services will restrict trading ahead of financial results release
18 SEPT 2026 | Friday
Nephrocare Health Services to consolidate Philippine subsidiaries, pending regulatory approvals
18 SEPT 2026 | Friday
Nephrocare Health Services Ltd. receives credit rating upgrades from India Ratings across loan facilities
14 SEPT 2026 | Monday
Nephrocare acquires Philippines dialysis center assets for PhP 67.2 million
17 AUG 2026 | Monday
Nephrocare Health Services acquires Philippines dialysis center assets for PhP 75 million
13 AUG 2026 | Thursday
Nephrocare acquires Davao City dialysis center assets for PhP 71.8 million
12 AUG 2026 | Wednesday
Nephrocare subsidiary in Kazakhstan, NPHSK LLP, holds KZT 5 million charter capital
11 AUG 2026 | Tuesday
Nephrocare Health Services’ revenue rose to Rs 2,817.54 crore, driven by India, Philippines, and Uzbekistan
24 JUL 2026 | Friday
Nephrocare Health Services announces board meeting date
17 JUL 2026 | Friday
Nephrocare Health Services to conduct AGM

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced

Frequently asked questions

The share price of Nephrocare Health Services Ltd is ₹637.65 as of 5 Oct 2026 at 15:52.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now